Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (99)	4/12/1998 3:06:00 PM
From: aknahow	Read Replies (2) \| Respond to of 4974

Rick, GNE is Genentech.<g> I know you know, I know, you know. Also was looking for the Vector Fund, on EDGAR, after getting the 10 K and annual report. I struck out on all the indicated variations. Perhaps they don't own over 5% of any company so are not required to file 13 Ds' I also thought the footnotes on the riskless collars or no cost collars created when GNE takes an equity position in a junior partner was instructive. It certainly allows a major pharma or a co. like GNE to provide equity capital with "assurance" that the equity stake will be valued at or near the original price at the time it was purchase. It made me have even more interest in the Vector Fund since I think these would be a different type of co which GNE was taking the investment risk. Appreciate anything you turn up in relation to the portfolio, of this, "later stage," Vector Fund. Is Vector at all related to the broker/dealer that appears to be used by BVF?